AstraZeneca

1,733.50 SEK

+0.93%

Less than 1K followers

AZN

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AstraZeneca

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)940.20828.401,062.801,403.501,353.501,446.501,703.50
Shares1,301.01,312.01,496.01,548.01,549.11,550.51,550.9
Market cap1,223,200.21,086,860.81,589,948.82,172,618.02,096,719.42,242,865.12,641,971.7
Enterprise value1,334,526.31,186,261.51,810,164.12,413,327.92,328,524.32,516,469.0-
EV/S6.15.45.35.25.04.2-
EV/EBITDA21.317.426.425.017.013.7-
EV/EBIT48.828.0189.361.628.222.8-
P/E98.041.41,567.263.434.928.928.1
P/B8.968.474.475.625.314.985.90
P/S5.65.04.74.74.53.84.9
Dividend yield2.8 %1.8 %2.4 %2.2 %2.2 %2.4 %1.7 %
Equity ratio23.8 %23.4 %37.3 %38.4 %38.7 %39.3 %42.7 %
Gearing ratio124.9 %130.3 %74.7 %78.9 %73.6 %74.1 %60.8 %